Compared with the IUGR group, dietary supplementation with 200 mg/kg of curcumin significantly decreased mRNA expression of caspase3, bax, and bcl2 in jejunal mucosa (p < 0.05). The gene discussed is BAX; the disease is fetal growth restriction.